Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by, and named after, Colonel Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War.

Company profile
Ticker
LLY
Exchange
Website
CEO
David Ricks
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
LILLY ELI & CO, LILLY ELI & CO ET AL
SEC CIK
Corporate docs
Subsidiaries
Akouos, Inc. • Alnara Pharmaceuticals, Inc. • Andean Technical Operations • ARMO Biosciences, Inc. • Avid Radiopharmaceuticals, Inc. • CoLucid Pharmaceuticals, Inc. • Compania Farmaceutica Eli Lilly de Centro America SA • Dermira, Inc. • Disarm Therapeutics Inc. • Dista Ilac Ticaret Limited ...
IRS number
350470950
LLY stock data
Analyst ratings and price targets
Latest filings (excl ownership)
SC TO-T/A
Third party tender offer statement (amended)
10 Aug 23
SC TO-T/A
Third party tender offer statement (amended)
9 Aug 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
8-K
Lilly Reports Second-Quarter 2023 Financial Results, Highlights Accelerating Revenue Growth and Key Pipeline Advancements
8 Aug 23
SC TO-T/A
Third party tender offer statement (amended)
1 Aug 23
SC TO-T/A
Third party tender offer statement (amended)
25 Jul 23
SC TO-T/A
Third party tender offer statement (amended)
18 Jul 23
SC TO-T/A
Third party tender offer statement (amended)
17 Jul 23
SC TO-T
Third party tender offer statement
13 Jul 23
SC TO-T
Third party tender offer statement
30 Jun 23
Transcripts
LLY
Earnings call transcript
2023 Q2
8 Aug 23
LLY
Earnings call transcript
2023 Q1
27 Apr 23
LLY
Earnings call transcript
2022 Q4
2 Feb 23
LLY
Earnings call transcript
2022 Q3
1 Nov 22
LLY
Earnings call transcript
2022 Q2
4 Aug 22
LLY
Earnings call transcript
2022 Q2
7 Jun 22
LLY
Earnings call transcript
2022 Q1
28 Apr 22
LLY
Earnings call transcript
2021 Q4
3 Feb 22
LLY
Earnings call transcript
2021 Q3
26 Oct 21
LLY
Earnings call transcript
2021 Q2
3 Aug 21
Latest ownership filings
4
Gabrielle Sulzberger
20 Sep 23
4
JUAN R LUCIANO
20 Sep 23
4
KIMBERLY H JOHNSON
20 Sep 23
4
Mary Lynne Hedley
20 Sep 23
4
J Erik Fyrwald
20 Sep 23
4
Ralph Alvarez
20 Sep 23
4
Alonzo Weems
13 Sep 23
144
Notice of proposed sale of securities
12 Sep 23
4
Change in insider ownership
8 Sep 23
144
Notice of proposed sale of securities
7 Sep 23
Financial summary
Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 2.69 bn | 2.69 bn | 2.69 bn | 2.69 bn | 2.69 bn | 2.69 bn |
Cash burn (monthly) | 283.80 mm | (no burn) | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 798.10 mm | n/a | n/a | n/a | n/a | n/a |
Cash remaining | 1.90 bn | n/a | n/a | n/a | n/a | n/a |
Runway (months of cash) | 6.7 | n/a | n/a | n/a | n/a | n/a |
Institutional ownership, Q2 2023
70.5% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 2663 |
Opened positions | 283 |
Closed positions | 153 |
Increased positions | 1013 |
Reduced positions | 1017 |
13F shares | Current |
---|---|
Total value | 312.89 tn |
Total shares | 669.54 mm |
Total puts | 6.49 mm |
Total calls | 5.78 mm |
Total put/call ratio | 1.1 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 69.92 mm | $32.79 tn |
BLK Blackrock | 64.45 mm | $30.23 tn |
PNC PNC Financial Services | 51.87 mm | $24.33 tn |
STT State Street | 33.88 mm | $15.89 tn |
FMR | 32.80 mm | $15.38 tn |
Capital World Investors | 26.87 mm | $12.60 tn |
T. Rowe Price | 24.16 mm | $11.28 tn |
Primecap Management | 23.55 mm | $11.04 tn |
State Farm Mutual Automobile Insurance | 17.36 mm | $8.11 tn |
Geode Capital Management | 15.21 mm | $7.11 tn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Sep 23 | Alvarez Ralph | Common Stock | Grant | Acquire A | No | No | 571.28 | 20 | 11.43 k | 53,379 |
18 Sep 23 | J Erik Fyrwald | Common Stock | Grant | Acquire A | No | No | 571.28 | 17 | 9.71 k | 71,368 |
18 Sep 23 | Hedley Mary Lynne | Common Stock | Grant | Acquire A | No | No | 571.28 | 17 | 9.71 k | 1,035 |
18 Sep 23 | Kimberly H Johnson | Common Stock | Grant | Acquire A | No | No | 571.28 | 17 | 9.71 k | 2,181 |
18 Sep 23 | Luciano Juan R | Common Stock | Grant | Acquire A | No | No | 571.28 | 25 | 14.28 k | 15,133 |
News
'Stocks In Monopolistic Bull Market': Wall Street Analyst Contemplates A Bright Future For Next Phase
22 Sep 23
U.S. FDA Approves Jardiance For The Treatment Of Adults With Chronic Kidney Disease
22 Sep 23
10 Health Care Stocks Whale Activity In Today's Session
21 Sep 23
Peering Into Eli Lilly's Recent Short Interest
20 Sep 23
Elon Musk-Backed Neuralink Starts Participant Enrollment For Paralysis, Eli Lilly Cracks Down on Counterfeit Weight Loss Drugs, Meta Looks to Capitalize on India's In-App Payment Surge: Today's Top Stories
20 Sep 23
Press releases
US FDA approves Jardiance® for the treatment of adults with chronic kidney disease
22 Sep 23
Demand for Abuse Deterrent Formulation Technology Skyrocketing as Opiate Abuse is on the Rise
20 Sep 23
Thinking about trading options or stock in Palantir Technologies, Broadcom, Eli Lilly And Co, General Electric, or Taiwan Semiconductor?
19 Sep 23
Scinai Immunotherapeutics Innovative Plaque Psoriasis Treatment Shows Encouraging Preclinical Results
13 Sep 23
Thinking about trading options or stock in Adobe, Macy's, Rocket Pharmaceuticals, Eli Lilly And Co, or Broadcom?
13 Sep 23